Emma C. Johnson

Mapping the genetic landscape across 14 psychiatric disorders

The Psychiatric Genomics Consortium: discoveries and directions

Multi-ancestry meta-analysis of tobacco use disorder identifies 461 potential risk genes and reveals associations with multiple health outcomes

The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies

Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders

Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals

Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implications

The Collaborative Study on the Genetics of Alcoholism: Overview

Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Multivariate analysis of 1.5 million people identifies genetic associations with traits related to self-regulation and addiction

Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts

Multi-omics integration analysis identifies novel genes for alcoholism with potential overlap with neurodegenerative diseases

Psychotic-like Experiences and Polygenic Liability in the Adolescent Brain Cognitive Development Study

The relationship between cannabis and schizophrenia: a genetically informed perspective

Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study

Integration of evidence across human and model organism studies: A meeting report

Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits

A large-scale genome-wide association study meta-analysis of cannabis use disorder

Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium

Shared genetic risk between eating disorder‐ and substance‐use‐related phenotypes: Evidence from genome‐wide association studies

Using polygenic scores for identifying individuals at increased risk of substance use disorders in clinical and population samples

Interpretation of psychiatric genome-wide association studies with multispecies heterogeneous functional genomic data integration

Genome-Wide Association Study of Opioid Cessation

Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders

Trans-ancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders

No Reliable Association between Runs of Homozygosity and Schizophrenia in a Well-Powered Replication Study